search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
news | Open house report Right: Arburg has


commenced pilot


deliveries of its largest machine to date, the 650 tonne Allrounder 1120


first injection machine to use the company’s new Gestica control system (the basic hardware and structure is also used in the Freeformer control system). Gaub described it as a high level controller that will eventually become the preferred option on all of its high end machines. However, he said the timescale for its introduction beyond the 1120 is still open and it is not an option that will be forced on custom- ers. “The proven Selogica system will be kept. We will give it a facelift but we will let the customer decide what they want to use,” he said. Gaub said the company


expects to take the first open orders for the Allrounder 1120 from Fakuma in October, with deliveries commencing in the second quarter of 2018.


Turnkey solutions Fully automated turnkey production cells continue to play an important part in the Arburg product offering and represented 17% of total sales in 2016, up from 15% the previ- ous year. It is an area that has seen considerable investment in recent years. Last year, for example, the company opened an 18,600m2


manufacturing


hall designed to support production and assembly of turnkey production systems. It houses 77 machine test stands, including 38 dedicated to more complex turnkey automation projects, and is now in full operation. Hehl said the company is


also investing to further develop the technical consult- ing expertise required to support turnkey projects. This


Arburg’s Gestica control, standard on the new Allrounder 1120, will become a standard high-end offering


includes areas such as automation, lightweight construction, medical technology and packaging, as well as broader manufacturing support services such as factory planning and Industry 4.0. This year, work will start on a new 13,700m2


multi-


storey building to enhance its abilities to offer customer training and seminars. Arburg has also extended its


consulting activities into the additive manufacturing sector with the formation of the Arburg Prototyping Centre, a new section within the company’s Plastic Freeforming unit that houses six Freeformer machines capable of producing 3D printed parts in any of six qualified materials. Gaub says the unit is not intended as a production resource but as a means to quickly benchmark designs. It is available to potential Freeformer buyers as well as to existing customers that may want to avoid time-consuming material changeovers on their own equipment (changing materials often involves a complete nozzle change and screw clean). During the Technology Days


The Arburg Prototyping Centre has been set up to support Freeformer additive manufacturing customers


16 INJECTION WORLD | March/April 2017


event, one of the Freeformer machines was demonstrating additive production of a compo- nent in aerospace-approved


PEI material. While the Freeformer machines have an obvious application in prototyp- ing, Gaub sees the aerospace sector – together with medical – as a key potential market for production of low volume or individualised versions of existing designs. Gaub said the Freeformer


can process a growing range of polymers including PP, ABS, PC, PA, amorphous PA, flame retarded ABS/PC blends, TPU and Ultem PEI and Arburg is evaluating new additions. The two key material


challenges in terms of additive manufacturing are shrinkage (especially challenging with semi-crystalline polymers) and abrasion. “We have made several metal and ceramic [powder] parts but the ‘problem’ is the nozzle; there is a high rate of wear,” he says. Arburg’s engineers are confident that filler wear issues can be overcome. However, processing of fibre reinforced materials presents an additional challenge as the fibres tend to block in the nozzle. “Powder, if it is very small, is OK. But fibres, we do not think so,” Gaub said. “At Fakuma we will show how we can do that in a different way. Additive manufacturing but not through a nozzle.”


www.injectionworld.com


PHOTO: ARBURG


PHOTO: ARBURG


PHOTO: ARBURG


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66